CIDD-0149897 is a potent, selective and brain-penetrant ERβ agonist. CIDD-0149897 exert antitumor functions in glioblastoma.
References:
[1]. Pratap UP, et, al. Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma. Mol Cancer Ther. 2023 Nov 1;22(11):1248-1260.
















